对瘤学药物的传统暴露-反应分析中依赖时间的混效应的评估和缓解
Xuefen Yin1, Ye Xiong2, Youwei Bi2
1Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, Florida, USA.
CPT: pharmacometrics & systems pharmacology
|September 26, 2025
概括
在瘤学中,传统的暴露-反应分析可能会由于混因素导致误导. 使用静态暴露指标和考虑多个证据来源可以提高准确性,以便更好地做出剂量决定.
科学领域:
- 制药指标 (Pharmacometrics) 是一个指标.
- 临床药理学 临床药理学
- 瘤学 药物开发 药物开发
背景情况:
- 暴露-反应 (ER) 分析对于瘤学剂量决定至关重要,通常使用关键试验数据.
- 使用汇总暴露指标的传统方法可能会被时间依赖因素所混,可能错误地描述真正的ER关系.
研究的目的:
- 调查由时间依赖的混因素影响的传统ER分析中的潜在错误表征.
- 评估暴露累积,剂量修改和事件发病时间对ER分析的影响.
- 提出减轻ER分析偏差的策略,以改善剂量决策.
主要方法:
- 基于模拟的方法被用于评估两个ER场景 (ER1:没有暴露效应;ER2:通过联合PK瘤模型的暴露驱动反应).
- 分析评估了时间依赖与静态暴露指标 (例如平均度,第一周期,稳定状态) 的影响.
- 该研究考虑了剂量修改 (中断/减少) 和事件发病时间的影响.
主要成果:
- 时间依赖的暴露指标可以诱导相反的 (暴露积累) 或正的 (剂量修改) E-R趋势.
- 发现静态暴露指标 (第一周期,稳定状态) 可以最大限度地减少这些偏差.
- 使用与真实E-R关系 (ER2) 结合的Emax模型,并结合剂量范围数据,可以减少偏差.
结论:
- 传统的E-R分析由于时间依赖的混因素,容易产生错误的描述.
- 建议使用静态暴露指标并评估跨多个指标的ER一致性.
- 综合证据方法,包括剂量反应结果,对于瘤学中可靠的剂量决定至关重要.
相关概念视频
Strategies for Assessing and Addressing Confounding
360
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
360
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
407
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
407
Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
401
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
401
Confounding in Epidemiological Studies
578
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
578
Time Course of Drug Effect
2.6K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.6K


